Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Consult a Professional This information is intended for educational purposes only and does not replace professional medical advice
Everyone responds to medications differently, and your Miami Primary clinician is here to work with you to optimize your outcome
From 7 injections/week 1 injection/week Same glycaemic control (HbA1c reduction) Comparable safety to daily basal insulin Backed by the ONWARDS Phase 3 program (~2,600+ patients), Awiqli demonstrated: Strong efficacy Consistent safety profile Flexibility with oral agents & GLP-1 therapies Strategic Takeaways (CI Lens): Convenience = Competitive Edge Improved adherence could translate into better real-world outcomes and stronger payer positioning
What BPC-157 vial sizes are available from research suppliers
US$ 21.09
US$ 26.43
US$ 22.93
US$ 26.40
US$ 27.11
US$ 23.90
US$ 22.61
US$ 20.06
US$ 26.50
